Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses

Author： Lundqvist Andreas   Palmborg Andreas   Bidla Gawa   Whelan Mike   Pandha Hardev   Pisa Pavel  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.21, Iss.2, 2004-06, pp. : 155-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The contribution of dendritic cells to immune responses against urological cancers - T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

By Troy A.   Davidson P.   Atkinson C.   Hart D.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 1, 1998-01 ,pp. : 17-23

Elsevier

Access to resources Recommend Favorite

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates

By Griffioen Marieke   Borghi Martina   Schrier Peter   Osanto Susanne   Schadendorf Dirk  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 715-722

Springer Publishing Company

Access to resources Recommend Favorite

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell–based cancer vaccination

By Galea-Lauri Joanna   Wells James   Darling David   Harrison Phillip   Farzaneh Farzin  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 963-977

Springer Publishing Company

Access to resources Recommend Favorite

Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma

By Yasuda Takashi   Kamigaki Takashi   Kawasaki Kentaro   Nakamura Tetsu   Yamamoto Masashi   Kanemitsu Kiyonori   Takase Shiro   Kuroda Daisuke   Kim Yongsik   Ajiki Tetsuo   Kuroda Yoshikazu  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1025-1036

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

By Romero Pedro   Cerottini Jean-Charles   Speiser Daniel  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 249-255

Springer Publishing Company

Access to resources Recommend Favorite